The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia
about
The role of miR-29b in cancer: regulation, function, and signalingMicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability.Pathogenic microRNA's in myeloid malignancies.NRF2-driven miR-125B1 and miR-29B1 transcriptional regulation controls a novel anti-apoptotic miRNA regulatory network for AML survival.Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin Bc-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell LineThe PU.1-Modulated MicroRNA-22 Is a Regulator of Monocyte/Macrophage Differentiation and Acute Myeloid Leukemia.Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia.MicroRNA-29b/Tet1 regulatory axis epigenetically modulates mesendoderm differentiation in mouse embryonic stem cells.MicroRNA biomarker identification for pediatric acute myeloid leukemia based on a novel bioinformatics model.Digging deep into "dirty" drugs - modulation of the methylation machinery.Fabrication of water-soluble polymer-encapsulated As4S4 to increase oral bioavailability and chemotherapeutic efficacy in AML mice.Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients.miR-29 regulates Tet1 expression and contributes to early differentiation of mouse ESCsmiRNAs in acute myeloid leukemia.microRNAs: role in leukemia and their computational perspective.MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemias.Targeting PI3K/AKT/mTOR network for treatment of leukemia.miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies.Micro-ribonucleic acid 29b inhibits cell proliferation and invasion and enhances cell apoptosis and chemotherapy effects of cisplatin via targeting of DNMT3b and AKT3 in prostate cancerc-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT.An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells.microRNA-451-modulated hnRNP A1 takes a part in granulocytic differentiation regulation and acute myeloid leukemia.High constitutive Akt2 activity in U937 promonocytes: effective reduction of Akt2 phosphorylation by the histamine H2-receptor and the β2-adrenergic receptor.Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis.MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.Triangle of AKT2, miRNA, and Tumorigenesis in Different Cancers.MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies.Coinhibition of overexpressed genes in acute myeloid leukemia subtype M2 by gold nanoparticles functionalized with five antisense oligonucleotides and one anti-CD33(+)/CD34(+) aptamer.Vav1 is necessary for PU.1 mediated upmodulation of miR-29b in acute myeloid leukaemia-derived cells.Understanding life and death decisions in human leukaemias.
P2860
Q26851543-E5193B60-EB17-4D28-B57B-EB9DF36BDE37Q29347524-CAAAA083-0527-4021-BF80-F97EA8B455C2Q34541057-4326EDA7-4D60-49AF-B991-41C5BC178F47Q35167587-A000F690-07D1-4660-9FC4-61056CEFAD10Q35612950-1417A229-97AC-4688-A164-026795067F15Q35783276-9A69B861-C6E6-47AF-B07A-E3D77F81233DQ36129863-80424B30-F0CD-40B4-BDF3-AEAD8ACCD704Q36262865-14F1FF78-C57B-4B8E-A141-4B43AB4D83FDQ36299130-54A4FAC7-CE3D-479C-AE1E-0BB723EFD494Q36413478-D17C7735-5000-43BF-BDB6-FB43F8139878Q36523796-768A1C1C-85BD-4F83-8303-6A1CA3A03D39Q37072906-C44E3C8C-1DFD-4300-A568-87E613BEBF29Q37327466-D5D369AB-004F-4A34-B75E-DCF7CA181551Q37662162-67923DE2-03F5-4F70-AFB1-57E203AE4F37Q37709531-FBBE6AF5-63A5-4187-ACDC-F05EFB64ADEEQ38240767-801737BF-CD97-4A24-BEA6-B72747180A19Q38252974-DD8525E2-605D-4D24-8FC1-FFF3779BB99EQ38364871-6D77632F-5A5B-4E92-9A57-CF8B43607390Q38476564-C5240493-CDB5-442D-99EE-C831022EA722Q38898187-33DAD27B-F1DD-433C-8929-C241D5CAF72DQ38987143-552B6777-494B-485F-961D-3233837AC0B1Q41092512-B4E80FCF-0C0C-476A-A39B-141318102F52Q41548277-D6E45D51-5BAD-4F1F-A046-1F90BF0D4509Q46652753-2323CD28-F2CD-46AA-825C-135724DDB33EQ47422423-184DA2E1-513E-490D-ADF6-F6E245A82B69Q48104779-9000295D-D3F8-43B4-AA56-1D64CDD820D6Q49333350-DFEF46D8-E049-4A34-ADD3-ABF71EA1461CQ49521797-2EB3B33D-3023-46FE-8A8B-14B2E036BCD4Q51204586-63552223-566E-46DC-A953-B8839BE43A63Q51734400-2DC8FA46-9BB0-44AD-BA98-99338B608A91Q55071953-3ED915D5-C5A3-4D1A-9564-67207B1BE84F
P2860
The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role, mechanism and potent ...... mily in acute myeloid leukemia
@en
The role, mechanism and potent ...... ily in acute myeloid leukemia.
@nl
type
label
The role, mechanism and potent ...... mily in acute myeloid leukemia
@en
The role, mechanism and potent ...... ily in acute myeloid leukemia.
@nl
prefLabel
The role, mechanism and potent ...... mily in acute myeloid leukemia
@en
The role, mechanism and potent ...... ily in acute myeloid leukemia.
@nl
P2093
P2860
P356
P1476
The role, mechanism and potent ...... mily in acute myeloid leukemia
@en
P2093
P2860
P2888
P304
P356
10.1038/CDD.2013.133
P50
P577
2013-09-27T00:00:00Z